297 related articles for article (PubMed ID: 24842896)
41. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.
Valkenburg O; Steegers-Theunissen RP; Smedts HP; Dallinga-Thie GM; Fauser BC; Westerveld EH; Laven JS
J Clin Endocrinol Metab; 2008 Feb; 93(2):470-6. PubMed ID: 18056772
[TBL] [Abstract][Full Text] [Related]
42. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
43. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease.
Cheung MC; Brown BG; Marino Larsen EK; Frutkin AD; O'Brien KD; Albers JJ
Biochim Biophys Acta; 2006 Jan; 1762(1):131-7. PubMed ID: 16216472
[TBL] [Abstract][Full Text] [Related]
44. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
[TBL] [Abstract][Full Text] [Related]
45. The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome.
Usta A; Avci E; Bulbul CB; Kadi H; Adali E
Reprod Biol Endocrinol; 2018 Apr; 16(1):34. PubMed ID: 29631598
[TBL] [Abstract][Full Text] [Related]
46. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
Barber TM; Casanueva FF; Karpe F; Lage M; Franks S; McCarthy MI; Wass JA
Eur J Endocrinol; 2008 Apr; 158(4):511-6. PubMed ID: 18362298
[TBL] [Abstract][Full Text] [Related]
47. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
Saxena R; Bjonnes AC; Georgopoulos NA; Koika V; Panidis D; Welt CK
Hum Reprod; 2015 Jul; 30(7):1697-703. PubMed ID: 25994816
[TBL] [Abstract][Full Text] [Related]
48. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
de Wilde MA; Goverde AJ; Veltman-Verhulst SM; Eijkemans MJ; Franx A; Fauser BC; Koster MP
Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
[TBL] [Abstract][Full Text] [Related]
49. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome.
Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562
[TBL] [Abstract][Full Text] [Related]
50. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes.
Tosi F; Bonora E; Moghetti P
Hum Reprod; 2017 Dec; 32(12):2515-2521. PubMed ID: 29040529
[TBL] [Abstract][Full Text] [Related]
51. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.
Berneis K; Rizzo M; Lazzarini V; Fruzzetti F; Carmina E
J Clin Endocrinol Metab; 2007 Jan; 92(1):186-9. PubMed ID: 17062762
[TBL] [Abstract][Full Text] [Related]
52. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
[TBL] [Abstract][Full Text] [Related]
53. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.
Carmina E; Chu MC; Moran C; Tortoriello D; Vardhana P; Tena G; Preciado R; Lobo R
Fertil Steril; 2008 Mar; 89(3):642-8. PubMed ID: 17562334
[TBL] [Abstract][Full Text] [Related]
54. [Relations of serum adipocyte fatty acid binding protein to sex hormone and lipoproteins in patients with polycystic ovary syndrome].
Hu WH; Qiao J; Li R; Wang LN
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3186-9. PubMed ID: 17313783
[TBL] [Abstract][Full Text] [Related]
55. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
56. Assessment of PON1 activity and circulating TF levels in relation to BMI, testosterone, HOMA-IR, HDL-C, LDL-C, CHO, SOD activity and TAC in women with PCOS: An observational study.
Jeelani H; Ganie MA; Masood A; Amin S; Kawa IA; Fatima Q; Manzoor S; Parvez T; Naikoo NA; Rashid F
Diabetes Metab Syndr; 2019; 13(5):2907-2915. PubMed ID: 31425955
[TBL] [Abstract][Full Text] [Related]
57. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
58. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
[TBL] [Abstract][Full Text] [Related]
59. Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion.
Pussinen PJ; Malle E; Metso J; Sattler W; Raynes JG; Jauhiainen M
Atherosclerosis; 2001 Apr; 155(2):297-305. PubMed ID: 11254899
[TBL] [Abstract][Full Text] [Related]
60. Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome.
Palomba S; Russo T; Falbo A; Di Cello A; Tolino A; Tucci L; La Sala GB; Zullo F
Hum Reprod; 2013 Oct; 28(10):2838-47. PubMed ID: 23756703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]